Pelthos Therapeutics (PTHS) Price to Book (2024 - 2026)
Pelthos Therapeutics (PTHS) posted Price to Book of 70.01 for Q2 2026, down 2005.11% on a QoQ basis from 3.67 in Q1 2026, and down 5259.95% year-over-year from 1.36 in Q2 2025.
Analysis
Pelthos Therapeutics (PTHS) Price to Book (2024 - 2026) Analysis & Trends
Pelthos Therapeutics has reported Price to Book for 3 years, with the latest figure at 70.01 in Q2 2026.
- On a quarterly basis, Price to Book fell 5259.95% year-over-year to 70.01 in Q2 2026; TTM through Jun 2026 was 70.01, a 5259.95% decrease from a year earlier, with the FY2026 full-year figure at 70.01, changed N/A from the prior year.
- Price to Book was 70.01 for Q2 2026 at Pelthos Therapeutics, down from 3.67 in the prior quarter.
- The five-year high for Price to Book was 10.88 in Q1 2024, with the low at 70.01 in Q2 2026.
- Average Price to Book over 3 years is 10.2, with a median of 1.37 recorded in 2024.
- The largest YoY upside for Price to Book was 275.61% in 2026 against a maximum downside of 5259.95% in 2026.
- Over 3 years, Price to Book stood at 1.44 in 2024, then jumped by 204.0% to 1.5 in 2025, then tumbled by 4769.57% to 70.01 in 2026.
- The last three Price to Book figures came in at 70.01 (Q2 2026), 3.67 (Q1 2026), and 1.5 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.84 Bn | 623.08 Bn | 17.26 Bn |
| 2 | AbbVie | 446.95 Bn | 440.38 Bn | 12.70 Bn |
| 3 | Merck | 360.43 Bn | 353.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.70 Bn | 261.01 Bn | 11.24 Bn |
| 5 | Pfizer | 156.98 Bn | 145.28 Bn | 10.94 Bn |
| 6 | Sanofi | 52.37 Bn | 44.99 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.71 Bn | 43.71 Bn | - |
| 8 | Incyte | 25.25 Bn | 20.71 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.39 Bn | 18.73 Bn | 683.80 Mn |
| 10 | Pelthos Therapeutics | 82.65 Mn | 58.09 Mn | 21.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -70.01 |
| Mar 31, 2026 | 3.67 |
| Dec 31, 2025 | 1.50 |
| Sep 30, 2025 | 1.49 |
| Jun 30, 2025 | -1.31 |
| Mar 31, 2025 | -2.09 |
| Dec 31, 2024 | -1.44 |
| Sep 30, 2024 | -2.89 |
| Jun 30, 2024 | -41.77 |
| Mar 31, 2024 | 10.88 |